{
    "nctId": "NCT00599924",
    "title": "Phase I Study Of SU011248 In Combination With Oxaliplatin, Leucovorin, And 5-Fluorouracil In Patients With Advanced Solid Malignancies",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Advanced solid tumor malignancy (during expansion at the maximum tolerated dose, entry will be limited to patients with adenocarcinoma of the colon or rectum)"
                    },
                    {
                        "type": "variable",
                        "value": "Eastern Cooperative Oncology Group (ECOG) 0 or 1"
                    },
                    {
                        "type": "variable",
                        "value": "Must have minimum age of 18 Years"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Prior treatment with more than 6 cycles of traditional alkylating agent-based chemotherapy regimens"
                            },
                            {
                                "type": "variable",
                                "value": "Prior treatment with more than 2 cycles of carboplatin-based chemotherapy regimens"
                            },
                            {
                                "type": "variable",
                                "value": "For colorectal cancer patients in the expanded cohorts, prior treatment with more than 2 systemic chemotherapy regimens in the metastatic setting"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('Advanced solid tumor malignancy (during expansion at the maximum tolerated dose, entry will be limited to patients with adenocarcinoma of the colon or rectum)'), Symbol('Eastern Cooperative Oncology Group (ECOG) 0 or 1'), Symbol('Must have minimum age of 18 Years'), Not(Or(Symbol('For colorectal cancer patients in the expanded cohorts, prior treatment with more than 2 systemic chemotherapy regimens in the metastatic setting'), Symbol('Prior treatment with more than 2 cycles of carboplatin-based chemotherapy regimens'), Symbol('Prior treatment with more than 6 cycles of traditional alkylating agent-based chemotherapy regimens'))))"
}